Biomimix, Inc.
Biomimix, Inc.
Your view on BMMX
Overview
What the company does, where it operates, and who runs it.
About Biomimix, Inc.
- Industry
- Conglomerates
- Sector
- Industrials
- CEO
- Jeff Conroy
- Headquarters
- US
- Industry
- Conglomerates
- Sector
- Industrials
- CEO
- Jeff Conroy
- Headquarters
- US
Biomimix, Inc. operates in the life science tools and services market covering genomics, proteomics, cell biology, analytical chemistry, bioprocess development, and bioinformatics in the United States. It develops and commercializes products based on processes and systems found in nature, known as biomimicry.
The company's product portfolio includes Bonegrafix products, which are bioactive substances to produce graft attributes for bone replacement and filling defects or holes in bone, or stabilizing bone during the healing process; and ocean water based skin care products to supplement skin health.
It also engages in the research and development of Medusa technology, an electro-chemical process that focuses on ballast water treatment, remote potable water treatment, and hydrogen production for use with portable renewable energy platforms.
The company was formerly known as C'watre International, Inc. and changed its name to Biomimix, Inc. in April 2009. Biomimix, Inc. was founded in 1986 and is based in Ashburn, Virginia.
Stock Data
Price chart, volume, and trading data.
FRC Fair Value Algorithm
What the FRC Fair Value algorithm says it is worth vs. the current price — FRC's own, on every stock.
About this section
Fair value for Biomimix, Inc. from FRC's valuation model, read against the market price. BMMX last traded at $2.58; the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for Biomimix, Inc.. Starting points for Biomimix, Inc.: EPS -$0.04, beta 0.32 — an Conglomerates name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
About this section
Dividend history, yield and payout sustainability for Biomimix, Inc.. Biomimix, Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for Biomimix, Inc.. Trailing twelve-month EPS for Biomimix, Inc. stands at -$0.04. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for Biomimix, Inc.. Biomimix, Inc. has reported as a listed company since 2000. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
More Conglomerates companies
Market cap
- MITSFMitsui & Co., Ltd.OTC$103.8B
- MITSYMitsui & Co., Ltd.OTC$105.8B
- MLCGML Capital Group, Inc.OTC$30,255
- MMM3M CompanyNYSE$93.6B
- MONIMoon Equity Holdings Corp.OTC$3M
- MSBHFMitsubishi CorporationOTC$124.2B
- MTSUYMitsubishi CorporationOTC$124.7B
- MVPTMVP Holdings Inc.OTC$56
- MXCHFOrbia Advance Corporation, S.A.B. de C.V.OTC$2.4B
- MXCHYOrbia Advance Corporation, S.A.B. de C.V.OTC$1.1B
- NICFFNichias CorporationOTC$3.7B
- NNBRNN, Inc.NASDAQ$265M
Institutional Ownership
Which funds and firms own the stock.
About this section
Which institutions hold Biomimix, Inc., and how their positions are changing. At a $139.4M market value, institutional positions materially move Biomimix, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.
Insider Trading
Recent buying and selling by company executives.
About this section
Buying and selling by Biomimix, Inc. executives and directors. Shares of Biomimix, Inc. have traded between $2.00 and $4.00 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.
Senate Trading
U.S. Senator disclosures filed under the STOCK Act.
About this section
U.S. Senate disclosures naming Biomimix, Inc.. Biomimix, Inc. is a $139.4M Industrials company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely.
House Trading
U.S. Representative disclosures filed under the STOCK Act.
About this section
U.S. House of Representatives disclosures naming Biomimix, Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals.
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for Biomimix, Inc.. Coverage tracks Biomimix, Inc. within Conglomerates (Industrials). Press releases and market coverage, newest first.
Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of Biomimix, Inc.